- Home
- LIPO vs TAOP Comparison
LIPO vs TAOP Comparison
Compare LIPO & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- TAOP
- Stock Information
- Founded
- LIPO 2005
- TAOP 1993
- Country
- LIPO United States
- TAOP China
- Employees
- LIPO N/A
- TAOP N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- TAOP Computer Software: Prepackaged Software
- Sector
- LIPO Health Care
- TAOP Technology
- Exchange
- LIPO Nasdaq
- TAOP Nasdaq
- Market Cap
- LIPO 3.1M
- TAOP 3.6M
- IPO Year
- LIPO 2022
- TAOP N/A
- Fundamental
- Price
- LIPO $2.57
- TAOP $0.26
- Analyst Decision
- LIPO Strong Buy
- TAOP
- Analyst Count
- LIPO 1
- TAOP 0
- Target Price
- LIPO $16.00
- TAOP N/A
- AVG Volume (30 Days)
- LIPO 45.5K
- TAOP 169.0K
- Earning Date
- LIPO 05-08-2025
- TAOP 05-05-2025
- Dividend Yield
- LIPO N/A
- TAOP N/A
- EPS Growth
- LIPO N/A
- TAOP N/A
- EPS
- LIPO N/A
- TAOP 0.50
- Revenue
- LIPO $536,357.00
- TAOP $42,636,173.00
- Revenue This Year
- LIPO N/A
- TAOP N/A
- Revenue Next Year
- LIPO N/A
- TAOP N/A
- P/E Ratio
- LIPO N/A
- TAOP $0.39
- Revenue Growth
- LIPO 19.29
- TAOP 37.49
- 52 Week Low
- LIPO $2.02
- TAOP $0.23
- 52 Week High
- LIPO $12.00
- TAOP $1.19
- Technical
- Relative Strength Index (RSI)
- LIPO 48.43
- TAOP 36.32
- Support Level
- LIPO $2.13
- TAOP $0.26
- Resistance Level
- LIPO $2.74
- TAOP $0.29
- Average True Range (ATR)
- LIPO 0.21
- TAOP 0.02
- MACD
- LIPO 0.05
- TAOP -0.00
- Stochastic Oscillator
- LIPO 76.06
- TAOP 22.43
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.